CELH
Celsius Holdings, Inc.
CELH has the edge over DNUT overall, supported by stronger fundamentals and stronger valuation.
DNUT
Krispy Kreme, Inc.
DNUT's outlook is improving, though it still trails on the overall score.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
DNUT Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Stable | |
| Stable | |
| Weak |
DNUT's profitability and cash flow are currently stable, but its revenue and balance sheet are under pressure.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH's PE is in its cheap range at 35x. If earnings grow as analysts expect, today's price would be 21x next year's earnings.
DNUT PE Valuation
DNUT has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 48x next year's earnings.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
CELH has the edge over DNUT on the outlook, with more favorable revenue expectations.
DNUT Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Stable | |
| Improving | |
| Limited | |
| Low |
Analysts expect DNUT to return to profit, with revenue holding steady. However, they disagree widely on these estimates.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH has the edge over DNUT on earnings quality, reporting a profit while its opponent remains loss making.
DNUT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.08 | — |
| Q3 2026 | -$0.54 | +$2.45 |
| Q2 2026 | -$0.57 | +$2.08 |
| Q1 2026 | -$3.00 | -$2.87 |
| Q4 2025 | -$3.04 | -15300% |
| Q3 2025 | -$2.99 | -1969% |
| Q2 2025 | -$2.65 | -$2.34 |
| Q1 2025 | -$0.13 | +$0.15 |
| Q4 2024 | $0.02 | +$0.25 |
DNUT lost $0.54 per share over the past year, a smaller loss than the year before.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH has the edge over DNUT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH has the edge over DNUT on profitability, with a higher operating margin.
DNUT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $328.8M | -12% |
| Q2 2026 | $331M | -13% |
| Q1 2026 | $367M | -2.2% |
| Q4 2025 | $392.4M | -2.9% |
| Q3 2025 | $375.3M | -1.2% |
| Q2 2025 | $379.8M | -13% |
| Q1 2025 | $375.2M | -15% |
| Q4 2024 | $404M | -10% |
DNUT's revenue has slid since its 2023 peak: $329M last quarter, down 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -2.7% | -0.8 points |
| Q2 2026 | -3.3% | +111 points |
| Q1 2026 | -1% | +4.4 points |
| Q4 2025 | -1.9% | +1 points |
| Q3 2025 | -1.9% | +2.3 points |
| Q2 2025 | -114% | -116 points |
| Q1 2025 | -5.4% | -8.1 points |
| Q4 2024 | -2.9% | -1.7 points |
DNUT's operating margin was −2.7% last quarter, down 0.8 points from the same quarter a year ago.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH still generates free cash flow, though less than at its 2025 peak: $269M over the past year.
DNUT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$3.8M | -125% |
| Q2 2026 | -$17.5M | +$43.2M |
| Q1 2026 | $11.4M | +$58.1M |
| Q4 2025 | $27.9M | +$34.8M |
| Q3 2025 | $15.5M | +$38.4M |
| Q2 2025 | -$60.8M | -3997% |
| Q1 2025 | -$46.7M | +$38K |
| Q4 2024 | -$6.9M | +$24.4M |
DNUT has the edge over CELH on cash flow, with more consistent year-over-year improvement.
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has the edge over DNUT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
DNUT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +900K shares |
| 1 year | +1.4% | +2.3M shares |
| 3 years | +3.1% | +5.3M shares |
| 5 years | +4.5% | +7.4M shares |
| Available history | +8.6% | +13.8M shares |
DNUT has 173M diluted shares, up 1.4% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $208,000 |
| Q2 2026 | $125,000 |
| Q1 2026 | $402,000 |
| Q4 2025 | $166,000 |
| Q3 2025 | $397,000 |
| Q2 2025 | $664,000 |
| Q1 2025 | $123,000 |
| Q4 2024 | $1.1M |
DNUT spent $901,000 buying back its own shares over the past year, down 61% from the year before.
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has the edge over DNUT on leverage, with a lower net debt burden relative to earnings.
DNUT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 9.4x | High |
| Q2 2026 | 8.7x | High |
| Q1 2025 | 10.4x | High |
| Q4 2024 | 7.0x | High |
| Q3 2024 | 6.2x | High |
| Q2 2024 | 6.3x | High |
| Q1 2024 | 6.4x | High |
| Q4 2023 | 6.1x | High |
DNUT's net debt is about 9.4 years of its operating earnings (EBITDA), up from 6.2 years a year ago.
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
DNUT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 55.1 | Neutral |
| Stochastic | 51.3 | Neutral |
DNUT's weekly RSI is 55 (neutral) and its Stochastic is 51 (neutral).
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
DNUT PE vs Consumer Defensive Sector
| Metric | DNUT | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 19x | — |
DNUT has no meaningful PE right now: it lost money over the past year.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 29% below its 200-week average.
DNUT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.22 | 15% above |
| 20 week MA | $3.28 | 13% above |
| 50 week MA | $3.50 | 6% above |
| 100 week MA | $4.17 | 11% below |
| 200 week MA | $8.55 | 57% below |
DNUT has the edge over CELH on trend strength, trading above more of its moving averages.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH's yearly returns have swung widely, from +832% in 2020 to −51% in 2024. It's down 30% so far in 2026.
DNUT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $19.1 | $16.9 | -12% |
| 2022 | $16.9 | $10.5 | -38% |
| 2023 | $10.5 | $15.1 | +44% |
| 2024 | $15.1 | $9.78 | -35% |
| 2025 | $9.78 | $4.28 | -56% |
| 2026 YTD | $4.28 | $3.71 | -13% |
DNUT has the edge over CELH on returns for 2026, with the stronger performance.